<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref130">
 <label>[130]</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Volakakis</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>Tiklova</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Decressac</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Papathanou</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Mattsson</surname>
   <given-names>B</given-names>
  </string-name>, 
  <string-name>
   <surname>Gillberg</surname>
   <given-names>L</given-names>
  </string-name>, 
  <string-name>
   <surname>Nobre</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Björklund</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Perlmann</surname>
   <given-names>T</given-names>
  </string-name> (
  <year>2015</year>) 
  <article-title>Nurr1 and retinoid X receptor ligands stimulate ret signaling in dopamine neurons and can alleviate 
   <italic>α</italic>-synuclein disrupted gene expression
  </article-title>. 
  <source>J. Neurosci</source>
  <volume>35</volume>, 
  <fpage>14370</fpage>–
  <lpage>14385</lpage>.
  <pub-id pub-id-type="pmid">26490873</pub-id>
 </mixed-citation>
</ref>
